Fusion Pharmaceuticals
FUSN
$21.43
Share price
0.00%
Change (1 day)
367.90%
Change (1 year)
Categories
Fusion Pharmaceuticals (FUSN) - Cash on Hand
Cash on Hand as of December 2023 : $0.23 B
According to Fusion Pharmaceuticals's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Fusion Pharmaceuticals - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.17 B | -14.9% |
| 2021-12-31 | $0.20 B | -9.71% |
| 2020-12-31 | $0.22 B | 240.35% |
| 2019-12-31 | $65.34 M | 127.14% |
| 2018-12-31 | $28.76 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -10.88% | 🇺🇸 USA |